The challenge of secondary prevention for coronary heart disease in older patients: findings from the British Women's Heart and Health Study and the British Regional Heart Study

被引:20
作者
Lawlor, DA
Whincup, P
Emberson, JR
Rees, K
Walker, M
Ebrahim, S
机构
[1] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England
[2] St George Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England
[3] Royal Free Hosp, Sch Med, Dept Primary Care & Populat Sci, London NW3 2PF, England
基金
英国医学研究理事会;
关键词
coronary heart disease; secondary prevention; aspirin; statin; older age;
D O I
10.1093/fampra/cmh516
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. Secondary prevention of coronary heart disease (CHD) among older individuals is associated with considerable benefit. Methods. In this study, we have examined the extent of secondary prevention among British women and men aged 60-79 years who were surveyed and examined between 1998 and 2001. Results. Among 483 women (12.1% of the whole sample) and 831 men (19.5%) with CHD, >90% of both sexes had at least one modifiable risk factor, with over two-fifths having high blood pressure and over three-quarters high cholesterol. For total cholesterol and body mass index, mean values in both male and female subjects were above recommended levels, and a large shift in the population distributions would be required for targets to be met. Less than one-quarter of subjects of either sex were on a statin, and whilst the majority of men were taking an antiplatelet medication, only 40% of women were. Conclusions. Most older women and men in Britain were failing to meet National Service Framework standards for secondary prevention in the period immediately before its implementation. Large shifts in the population distributions of some risk factors would be required in this group to meet these standards.
引用
收藏
页码:582 / 586
页数:5
相关论文
共 5 条
[1]  
Department of Health, 2000, NAT SERV FRAM COR HE
[2]   Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial [J].
Hunt, D ;
Young, P ;
Simes, J ;
Hague, W ;
Mann, S ;
Owensby, D ;
Lane, G ;
Tonkin, A .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (10) :931-940
[3]   Patients with acute coronary syndrome should start a statin while still in hospital [J].
Isles, CG .
HEART, 2002, 88 (01) :5-6
[4]   Is the association between parity and coronary heart disease due to biological effects of pregnancy or adverse lifestyle risk factors associated with child-rearing? - Findings from the British women's heart and health study and the British regional heart study [J].
Lawlor, DA ;
Emberson, JR ;
Ebrahim, S ;
Whincup, PH ;
Wannamethee, SG ;
Walker, M ;
Smith, GD .
CIRCULATION, 2003, 107 (09) :1260-1264
[5]   Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care [J].
Murchie, P ;
Campbell, NC ;
Ritchie, LD ;
Simpson, JA ;
Thain, J .
BRITISH MEDICAL JOURNAL, 2003, 326 (7380) :84-+